Ivan S. Ciric, M.D.

Ivan S. Ciric, M.D.

Ivan S. Ciric, M.D.


General Information




Independent Practitioner


Pituitary Tumors, Brain & Skull Based Tumors



Board Certified

Neurological Surgery

Clinical Service

Education, Training & Fellowships

Medical School

University of Belgrade, 1958


Northwestern Feinberg School of Medicine
University of Belgrade, 1961


Veterans Affairs Lakeside Medical Center
St. Hedwig Klinik, 1963
Neurosurgical Clinic of the University of Cologne, 1963
Wesley Memorial Hospital, 1966


Montefiore Hospital - Montreal



Evanston Hospital

2650 Ridge Ave.
Burch 226
Evanston, IL 60201
847.570.1442 fax
Get Directions This location is not wheelchair accessible.


For information on the insurance plans this provider accepts:
  • Call: 847.570.1440


  • Minimally-invasive trans-sulcal resection of Intra-ventricular and Peri-ventricular lesions through a tubular retractor system: Multi-centric experience and results.

    World neurosurgery 2016 Jan 21

    Authors: Eliyas JK, Glynn R, Kulwin CG, Rovin R, Young R, Alzate J, Pradilla G, Shah MV, Kassam A, Ciric I, Bailes J
    Conventional approaches to deep-seated cerebral lesions range from biopsy to trans-cortical or trans-callosal resection. While the former doesn't reduce tumor burden, the latter are more invasive and associated with greater potential for irreparable injury to normal brain. Disconnection syndrome, hemiparesis, hemi-anesthesia or aphasia is not uncommon after such surgery, especially when lesion is large. By contrast, the trans-sulcal parafascicular approach utilizes naturally existing corridors and employs a tubular retractor to minimize brain injury.
    A retrospective review of patients undergoing minimally invasive trans-sulcal parafascicular resection of ventricular and periventricular lesions, across 5 independent centers, were conducted.
    Twenty patients with lesions located in the lateral ventricle (n=9), the third ventricle (n=6) and periventricular region (n=4) are described in this report. Average age was 64 years (8M/12F). Average depth from cortical surface was 4.37 cm. A 13.5 mm diameter tubular retractor (Brainpath, NICO Corporation, Indianapolis, IN) of differing lengths was employed, aided by neuro-navigation. Gross-total resection was obtained in 17 patients. Pathologies included colloid cyst, subependymoma, glioma, meningioma, central neurocytoma, lymphoma and metastasis. Three patients experienced transient morbidity: memory loss (2), hemiparesis (1). One patient died 2 months postoperatively due to unrelated pulmonary illness. Follow-up ranged form 6 to 27 months (average 12 months).
    This technique is safe and effective for the treatment of intraventricular and periventricular lesions. Surgery-related morbidity is minimal and often transient. Lesions are satisfactorily resected and residuum occur when neoplasm involves vital structures. The tubular retractor minimizes trauma to brain incident on the surgeon's path.
    PMID: 26805678 [PubMed - as supplied by publisher]
  • Craniopharyngiomas and Visual Loss.

    World neurosurgery 2015 Jun

    Authors: Cirić I
    The United States health care is presently challenged by a significant economic crisis. The purpose of this report is to introduce the readers of Medicinski Pregled to the root causes of this crisis and to explain the steps undertaken to reform health care in order to solve the crisis. It is hoped that the information contained in this report will be of value, if only in small measure, to the shaping of health care in Serbia.
    PMID: 25460049 [PubMed - as supplied by publisher]
  • Transplanum approach to suprasellar lesions.

    World neurosurgery

    Authors: Ammirati M, Wei L, Ciric I
    Endoscopic transsphenoidal pituitary surgery has become increasingly more popular for the removal of pituitary adenomas. It is also widely recognised that transsphenoidal microscopic removal of pituitary adenomas is a well-established procedure with good outcomes. Our objective was to meta-analyse the short-term results of endoscopic and microscopic pituitary adenoma surgery. We undertook a systematic review of the English literature on results of transsphenoidal surgery, both microscopic and endoscopic from 1990 to 2011. Series with less than 10 patients were excluded. Pooled data were analysed using meta-analysis techniques to obtain estimate of death, complication rates and extent of tumour removal. Complications evaluated included cerebrospinal fluid leak, meningitis, vascular complications, visual complications, diabetes insipidus, hypopituitarism and cranial nerve injury. Data were also analysed for tumour size and sex. 38 studies met the inclusion criteria yielding 24 endoscopic and 22 microscopic datasets (eight studies included both endoscopic and microscopic series). Meta-analysis of the available literature showed that the endoscopic transsphenoidal technique was associated with a higher incidence of vascular complications (p<0.0001). No difference was found between the two techniques in all other variables examined. Meta-analysis of the available literature reveals that endoscopic removal of pituitary adenoma, in the short term, does not seem to confer any advantages over the microscopic technique and the incidence of reported vascular complications was higher with endoscopic than with microscopic removal of pituitary adenomas. While we recognise the limitations of meta-analysis, our study suggests that a multicentre, randomised, comparative effectiveness study of the microscopic and endoscopic transsphenoidal techniques may be a reasonable approach towards establishing a true valuation of these techniques.
    PMID: 23500340 [PubMed - as supplied by publisher]
  • U.S. health care: a conundrum and a challenge.

    World neurosurgery 2013 Dec

    Authors: Ciric IS
    This report was conceived as a contribution to the national debate regarding U.S. health care (HC) and as a means of explaining the challenges facing U.S. HC to the international readers of WORLD NEUROSURGERY.
    The basic economic concepts pertinent to health care, including fundamentals of economic theories, gross domestic product (GDP), U.S. revenues and expenditures and the U.S. federal deficit and national debt, are discussed at the outset of this study. This is followed by a review of the U.S. health insurance paradigms and a detailed analysis of the escalating cost of U.S. health care. Finally, the efforts designed to reverse the paradigm of escalating health care costs will be discussed.
    This study reveals that should the U.S. HC cost continue to escalate at the same rate, HC would consume the entire gross domestic product by 2070. The root causes for this trend are overutilization of HC, inappropriate allocation of HC costs at the end of life, defensive medicine, high-end technology and prescription drugs, failure of competitive market forces, and administrative costs, inefficiency, and waste. The proposed means of reversing this paradigm, including the Patient Protection and Affordable Care Act, are discussed in light of their economic and social impact.
    The reversal of the current paradigm of escalating cost of U.S. HC will require extraordinary leadership across the entire spectrum of HC delivery. It is concluded that neither the Affordable Care Act nor the Path to Prosperity will succeed unless the escalating cost of U.S. HC is reversed. It is hoped that this report contributes to that end.
    PMID: 23131431 [PubMed - as supplied by publisher]
× Alternate Text